Report cover image

Global Prostate Cancer Antigen 3 Test Supply, Demand and Key Producers, 2026-2032

Publisher GlobalInfoResearch
Published Jan 09, 2026
Length 93 Pages
SKU # GFSH20701689

Description

The global Prostate Cancer Antigen 3 Test market size is expected to reach $ 111 million by 2032, rising at a market growth of 8.9% CAGR during the forecast period (2026-2032).

The prostate cancer antigen 3 gene (PCA3) test is used to assess your risk of developing prostate cancer. It is not used to make a diagnosis of prostate cancer. It is primarily used to determine whether your elevated prostate-specific antigen (PSA) levels are the result of prostate cancer. Prostate cancer is a type of cancer that develops in the prostate gland of men and is increasing at a significant rate each year. This cancer is commonly found in the elderly population, and it can have serious consequences such as blood in the sperm, bone pain, and erectile dysfunction, among others. As a result, early detection is required to avoid it at an early stage.

The Global key players of Prostate Cancer Antigen 3 Test include Hologic, Thermo Fisher Scientific, MDxHealth, etc. The top three players hold a share about 77%. US & Canada is the largest market, and has a share about 37%. In terms of product type, RT-PCR is the largest segment, which occupied for a share of about 87%. For application, Hospital is the largest segment, which has a share about 61%.

This report studies the global Prostate Cancer Antigen 3 Test demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Prostate Cancer Antigen 3 Test, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Prostate Cancer Antigen 3 Test that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Prostate Cancer Antigen 3 Test total market, 2021-2032, (USD Million)

Global Prostate Cancer Antigen 3 Test total market by region & country, CAGR, 2021-2032, (USD Million)

U.S. VS China: Prostate Cancer Antigen 3 Test total market, key domestic companies, and share, (USD Million)

Global Prostate Cancer Antigen 3 Test revenue by player, revenue and market share 2021-2026, (USD Million)

Global Prostate Cancer Antigen 3 Test total market by Type, CAGR, 2021-2032, (USD Million)

Global Prostate Cancer Antigen 3 Test total market by Application, CAGR, 2021-2032, (USD Million)

This report profiles major players in the global Prostate Cancer Antigen 3 Test market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hologic, Thermo Fisher Scientific, MDxHealth, Exosome Diagnostics GmbH, Copyright Creative Diagnostics, Lytech, YUBO, MicroDiag Biomedicine, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Prostate Cancer Antigen 3 Test market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.

Global Prostate Cancer Antigen 3 Test Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Prostate Cancer Antigen 3 Test Market, Segmentation by Type:
RT-PCR
ELISA Test

Global Prostate Cancer Antigen 3 Test Market, Segmentation by Application:
Hospital
Diagnosis Center
Other

Companies Profiled:
Hologic
Thermo Fisher Scientific
MDxHealth
Exosome Diagnostics GmbH
Copyright Creative Diagnostics
Lytech
YUBO
MicroDiag Biomedicine

Key Questions Answered

1. How big is the global Prostate Cancer Antigen 3 Test market?

2. What is the demand of the global Prostate Cancer Antigen 3 Test market?

3. What is the year over year growth of the global Prostate Cancer Antigen 3 Test market?

4. What is the total value of the global Prostate Cancer Antigen 3 Test market?

5. Who are the Major Players in the global Prostate Cancer Antigen 3 Test market?

6. What are the growth factors driving the market demand?

Table of Contents

93 Pages
1 Supply Summary
2 Demand Summary
3 World Prostate Cancer Antigen 3 Test Companies Competitive Analysis
4 United States VS China VS Rest of World (by Headquarter Location)
5 Market Analysis by Type
6 Market Analysis by Application
7 Company Profiles
8 Industry Chain Analysis
9 Research Findings and Conclusion
10 Appendix

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us